Stockreport

SciClone Pharmaceuticals beats by $0.06, beats on revenue [Seeking Alpha]

SCICLONE PHARMACEUTICALS  (SCLN) 
US:NASDAQ Investor Relations: sciclone.com
PDF SciClone Pharmaceuticals (NASDAQ: SCLN ): Q2 EPS of $0.30 . Revenue of $44.5M (+14.1% Y/Y) . Press Release Now read: My Final Thoughts On Dynavax Befo [Read more]